Trade ALKS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Alkermes plc (ALKS) is trading at US$47.83, down 2.20% today as of Aug 28, 12:01 EDT. The company has a market capitalisation of US$8.11B. Over the past 52 weeks, ALKS has traded between US$25.17 and US$55.67. On Syfe you can trade ALKS with $0 commission and add it to your watchlist.
| Previous close | US$48.90 |
|---|---|
| Market cap | US$8.11B |
| P/E ratio | 182.60 |
| 52-week range | US$25.17 – US$55.67 |
| Volume | 2.05M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Alkermes plc
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.
Year: 1991
Alkermes' Core Business Backed Q2 Beat, Orexin Pipeline to Serve as Catalyst, RBC Says
Jul 29, 3:53 PM · MT Newswires
Correction: Alkermes Posts Q2 Breakeven Earnings, Revenue Rises; Reiterates 2026 Revenue Guidance
Jul 28, 12:13 PM · MT Newswires
Alkermes Q2 Earnings Flat, Revenue Rises; Reiterates 2026 Revenue Guidance
Jul 28, 11:42 AM · MT Newswires
-- Earnings Flash (ALKS) Alkermes Public Company Posts Q2 EPS Breakeven, vs. FactSet Est of $0.03 Loss
Jul 28, 11:20 AM · MT Newswires
Alkermes plc (ALKS) stock is trading at US$47.83, -2.20% from the previous close of US$48.90.
The market cap for Alkermes plc (ALKS) stock is approximately US$8.11B.
The price-to-earnings ratio for Alkermes plc (ALKS) is 182.60, based on the latest reported earnings.
The 52-week high for Alkermes plc (ALKS) stock is US$55.67.
The 52-week low for Alkermes plc (ALKS) stock is US$25.17.
Alkermes plc (ALKS) does not currently pay a dividend.
Stay on top of ALKS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
